# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-12T18:38:00.000000
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 11934 in / 5705 out
**Response SHA256:** b55b46d345186a1d

---

Thank you for the opportunity to review this paper. The question—whether weakening the market for corporate control contributed to the long-run decline in business dynamism—is important, timely, and potentially high-impact. The paper brings a valuable aggregate perspective to a literature that has emphasized firm- and plant-level effects of anti-takeover statutes. The use of heterogeneity-robust staggered DiD estimators (Callaway & Sant'Anna; Sun & Abraham) is appropriate and a necessary advance relative to the older TWFE literature.

Below I provide a comprehensive referee report organized around the requested checklist: format, statistical methodology, identification, literature, writing quality, constructive suggestions, overall assessment, and a decision.

1. FORMAT CHECK

- Length: The LaTeX source is a full paper. From the source structure and number of sections, the draft looks to be roughly 30–40 pages (main text plus appendix and figures/tables). This exceeds the 25-page threshold (excluding references/appendix). Good.

- References: The bibliography (via \bibliography{references}) cites many relevant works (Bertrand et al. 2003; Giroud & Mueller 2010; Callaway & Sant'Anna 2021; De Loecker et al.; Decker et al.). However several important methodological and applied references are missing (see Section 4 below). Please ensure the .bib file includes the methodological papers I list.

- Prose: Major sections (Introduction, Institutional Background, Theoretical Framework, Data, Empirical Strategy, Results, Robustness, Discussion, Conclusion) are written in paragraph form. No problematic use of bullets in the main narrative, except small lists in institutional background and data sample restrictions (these are fine).

- Section depth: Major sections (Intro, Institutional Background, Theory, Data, Empirical Strategy, Results, Discussion) are substantive and contain multiple paragraphs—each appears to have 3+ paragraphs. Satisfactory.

- Figures: The LaTeX source references several figures (map, rollout, raw trends, event studies). I cannot see rendered PDFs in this source review, but the figure inclusion commands point to external PDFs (e.g., figures/fig1_adoption_map.pdf). Please verify in the compiled submission that all figures have labeled axes, units, legend, and readable fonts. In particular, event-study figures should show 95% CIs around point estimates and a horizontal zero line.

- Tables: The source inputs tables (e.g., \input{tables/tab3_main}). I could not inspect the rendered numbers here, but the manuscript text reports coefficients, p-values, and some SE information. Ensure every regression table explicitly reports coefficient estimates with standard errors (in parentheses), number of observations, number of clusters (states), R-squared where relevant, and clear table notes explaining estimation method, sample, outcome definitions, and whether results are from Callaway-Sant'Anna, Sun-Abraham, or TWFE. (See methodological checklist below.)

2. STATISTICAL METHODOLOGY (CRITICAL)

A paper cannot pass review without correct and transparent statistical inference. Below I first summarize what the paper does correctly, then list methodological issues that need to be addressed before publication.

What the paper does well:
- The author uses heterogeneity-robust staggered DiD estimators: Callaway & Sant'Anna (2021) as the baseline and Sun & Abraham (2021) as a robustness check. This is the correct modern approach for staggered adoption.
- The author clusters standard errors at the state level and supplements asymptotic inference with randomization inference (500 permutations). This is appropriate and good practice.
- The paper reports p-values and discusses multiple testing (Bonferroni correction).

Critical requirements / issues to fix (fatal if not addressed):
a) Standard errors and inference reporting
- Requirement: Every coefficient must show standard errors (or CIs) and sample sizes (N). In the source I cannot see the numeric table output, but the text cites coefficients and p-values. The author must ensure all main tables include: coefficient, (cluster-robust standard error), N (state-year obs), number of clusters (states), and explicit statement of whether reported p-values are cluster-robust or from randomization inference. For the Callaway-Sant'Anna estimator, report either bootstrap standard errors (how many draws) or analytic standard errors as implemented; be explicit in table notes.
- Include 95% confidence intervals for main results (either in the table or via figure error bars). The event-study figures should display 95% CIs.

b) Significance testing
- The paper reports p-values for main coefficients. Good. But for heterogeneity-robust estimators (Callaway-Sant'Anna), standard errors are typically bootstrapped. Please state the bootstrap procedure (e.g., 500/1,000 bootstrap replications) and whether blocking or wild cluster bootstrap was used. Given only 50 clusters, using the wild cluster bootstrap-t (Cameron, Gelbach & Miller 2008 / Cameron & Miller 2015) or permutation inference is advisable as robustness.

c) Sample sizes
- N must be reported for every regression. Some cohorts/adopters are dropped because CBP starts in 1988—please report exactly how many state-year observations each estimation uses. For the Callaway-Sant'Anna ATT, show the count of group-time cells used. Add a table showing the number of treated and never-treated states used in the main identification for each outcome.

d) Staggered DiD concerns
- The paper correctly states that TWFE is problematic and uses Callaway-Sant'Anna and Sun-Abraham. This is good and the right practice. However, two implementation details need clarification and additional robustness:
  1) Base period selection: you indicate you use "universal base period" where all pre-treatment periods inform the parallel trends comparison. For cohorts lacking any pre-period observations (the earlier adopters), Callaway-Sant'Anna drops them. The paper acknowledges this. But the consequence is that estimation leverages only the 1988–1997 cohorts. You must be explicit in tables/appendix about which cohorts contribute to which event-study estimates and how many cohorts/time cells are in each event-time bin (especially for long leads/lags where fewer cohorts contribute). Event-study inference for long horizons with few contributing cohorts can be fragile.
  2) Heterogeneous dynamic effects: Callaway-Sant'Anna estimates group-time ATTs and aggregates them using weights. Show the cohort-specific ATTs (or at least cohort-grouped estimates) in an appendix figure or table to check whether aggregation masks divergent cohort patterns. If certain cohorts drive the result, report that.

e) Inference with 50 clusters and serial correlation
- You cluster at the state level—correct. But with 50 clusters and serial correlation, asymptotic approximations can be unreliable. You do run randomization inference (500 permutations). Complement this with wild cluster bootstrap-t or at least report bootstrap-based p-values and compare. Provide details of the randomization inference (what was permuted: treatment adoption dates across states? Was the permutation constrained by number of treated states?).

f) RDD (not applicable)
- RDD requirements (bandwidth sensitivity, McCrary test) are not relevant here.

g) Pre-trend testing
- The paper shows event-study pre-treatment coefficients "cluster around zero." Good. But given early adopters are dropped and long pre-period bins have fewer cohorts, test pre-trends formally using placebo leads and conduct F-tests for joint significance of pre-treatment coefficients. Provide these p-values in tables or notes.

h) Multiple testing
- You corrected with Bonferroni for three outcomes—reasonable. Consider reporting q-values or using the Romano-Wolf procedure if many outcomes are tested. At a minimum explicitly state the multiple-testing correction used and present both raw and adjusted p-values.

If these inference reporting and robustness items are not addressed, the statistical inference will be insufficient. The most fatal omission would be failing to include standard errors/CIs and sample sizes in the actual regression tables.

3. IDENTIFICATION STRATEGY

Credibility: The identification strategy is plausible but requires more explicit diagnostics and extensions to strengthen causal claims.

Strengths:
- Exploits staggered timing of BC adoptions and uses modern staggered DiD methods—appropriate.
- Uses never-treated states as controls.
- Conducts event-study pre-trend analysis, placebo tests (shifting treatment), and randomization inference.
- Considers several validity threats (incorporation vs. location, endogenous adoption, concurrent policies) and runs robustness checks (dropping lobbying-driven adopters, excluding Delaware).

Concerns and suggestions:

a) Incorporation vs. location (major concern)
- This is the paper's single largest substantive threat (admitted in Section "Threats to Validity" and in Discussion). BC statutes apply by state of incorporation; CBP outcomes measure establishments by physical location. Many large firms incorporate in Delaware. If a state's adoption changes legal environment for firms incorporated in that state but those firms' plants are located elsewhere, CBP state-level outcomes will be a noisy measure of exposure. The paper handles this by (1) dropping Delaware and (2) arguing that many local employers are incorporated in their home state. This is not sufficient.
- Suggested fix (required for stronger causal interpretation): construct an incorporation-weighted exposure measure for each state-year using firm incorporation data (e.g., from Compustat/CRSP or state incorporation records). Two approaches:
  1) State-level exposure = fraction of state employment (or payroll, establishments) accounted for by firms incorporated in that state (using Compustat firm-headquarter/incorporation mapping). Use that as a continuous treatment (difference-in-differences with continuous treatment intensity), or instrument the binary adoption with the fraction exposed.
  2) Run firm-level regressions: collapse Compustat/LEI-level firms by state of incorporation (or firm-level panel) and trace effects on firm-level outcomes (employment, acquisitions, investment, patenting) using adoption by incorporation-state as treatment. Aggregation of firm-level effects yields a treatment-on-treated estimate.
- Rationale: this strategy directly measures who is legally affected and separates incorporation effects from location-based macro outcomes. If incorporation-weighted exposure is highly correlated with the binary treatment indicator then state-level CBP effects are more credible; if not, the binary estimates may understate or misstate the effect.

b) Endogenous adoption
- The paper addresses endogenous adoption by excluding documented lobbying states and testing pre-trends. This is good, but more is needed:
  - Provide robustness where treatment timing is instrumented by plausibly exogenous determinants (e.g., CTS court decision timing interacted with state-level political variables or legislative calendar features) or use diffusion/mimicry instruments (distance to early adopters, percent of neighboring states already adopted) as instruments for adoption timing—carefully justified.
  - Alternatively, use synthetic control approaches for selected treated states with detailed pre-period data to corroborate DiD findings.

c) Early adopters lack pre-period data
- Several earliest adopters (NY 1985, IN/NJ 1986, several 1987) are already treated by 1988 and dropped. As the author notes, this means identification comes primarily from 1988–1997 adopters. More transparency is needed on which states are in the identification sample. Also, re-estimate results restricting to cohorts with sufficient pre-period length and show consistency.

d) Dynamic general equilibrium / spillovers
- BC statutes in one state might affect neighboring states through firm relocation or acquisition activity across state lines. Consider testing for spatial spillovers (e.g., using neighboring states' adoption as regressors) or including state-specific linear trends as robustness. Report whether results change with state-specific trends.

e) Mechanisms and heterogeneity
- The paper interprets reduced net entry as creative-destruction channel and reduced size as less M&A-driven consolidation. To strengthen claims, provide mechanism evidence:
  - Show M&A activity by state-year (if available) declines after adoption. Data on acquisitions by state of acquirer or target (e.g., Thomson Reuters SDC, Zephyr) could help.
  - Use industry-level heterogeneity: the paper hypothesizes effects concentrate in less competitive industries; decompose effects by manufacturing vs services, or by HHI industry concentration, or by 4-digit NAICS groups to show stronger effects where Giroud & Mueller predict them.
  - Firm-level outcomes such as patenting (Atanassov 2013), investment, productivity, or exit would help link micro mechanisms to aggregate results.

f) Pre-trend tests: formal joint tests
- Report joint F-tests and p-values for pre-treatment coefficients. For net entry the manuscript notes some longer-horizon pre-trend deviations—this must be examined carefully. If pre-trends are present, explore reasons (differential cycles, measurement) or consider reweighting or matching treated to similar never-treated states.

4. LITERATURE (Provide missing references)

The paper cites many relevant empirical and theoretical references. However, several foundational methodological and applied papers should be cited and discussed explicitly. Below I list recommended additions, why they are relevant, and provide BibTeX entries to include.

Methodological references (DiD/staggered timing/inference):

- Goodman-Bacon (2021) — explains TWFE decomposition and contamination bias; paper references him but please include full citation.
  @article{goodmanbacon2021difference,
    author = {Goodman-Bacon, Andrew},
    title = {Difference-in-differences with variation in treatment timing},
    journal = {Journal of Econometrics},
    year = {2021},
    volume = {225},
    pages = {254--277}
  }

- Sun & Abraham (2021) — interaction-weighted estimator used as robustness; cite full reference.
  @article{sun2021estimating,
    author = {Sun, Liyang and Abraham, Sarah},
    title = {Estimating dynamic treatment effects in event studies with heterogeneous treatment effects},
    journal = {Journal of Econometrics},
    year = {2021},
    volume = {225},
    pages = {175--199}
  }

- Callaway & Sant'Anna (2021) — already cited; make sure full citation (journal, volume) is included.
  @article{callaway2021difference,
    author = {Callaway, Brantly and Sant'Anna, Pedro H.C.},
    title = {Difference-in-differences with multiple time periods},
    journal = {Journal of Econometrics},
    year = {2021},
    volume = {225},
    pages = {200--230}
  }

- Cameron, Gelbach & Miller (2008) / Cameron & Miller (2015) — inference with few clusters and wild cluster bootstrap recommendation.
  @article{cameron2008bootstrap,
    author = {Cameron, A. Colin and Gelbach, Jonah B. and Miller, Douglas L.},
    title = {Bootstrap-based improvements for inference with clustered errors},
    journal = {The Review of Economics and Statistics},
    year = {2008},
    volume = {90},
    pages = {414--427}
  }
  @article{cameron2015practical,
    author = {Cameron, A. Colin and Miller, Douglas L.},
    title = {A practitioner's guide to cluster-robust inference},
    journal = {Journal of Human Resources},
    year = {2015},
    volume = {50},
    pages = {317--372}
  }

- Roth (2022/2023) on event-study inference and issues with leads/lags (you cite Roth 2023; ensure full ref).

Empirical and instruments / firm-level corporate governance literature:

- Manne (1965), Jensen (1986) — already cited as background.

- Bertrand, Mehta & Mullainathan (2002/2003) — Bertrand et al. 2003 is cited.

- Karpoff & Wittry / Karpoff (2018) — you cite Karpoff 2018; ensure full entry.

- Additional empirical pieces on BC statutes and corporate control I recommend citing:
  - Bebchuk, Cohen & Ferrell (2009) on corporate governance changes, anti-takeover provisions.
  @article{bebchuk2009what,
    author = {Bebchuk, Lucian A. and Cohen, Alma and Ferrell, Allen},
    title = {What matters in corporate governance?},
    journal = {The Review of Financial Studies},
    year = {2009},
    volume = {22},
    pages = {783--827}
  }

- On market power and dynamism literature: Autor et al. (2020) and Barkai (2020) are already cited; consider adding Gutiérrez & Philippon (2017) on investment and market power.
  @article{gutierrez2017investment,
    author = {Gutiérrez, Germán and Philippon, Thomas},
    title = {Investment-less growth: An empirical investigation},
    journal = {Brookings Papers on Economic Activity},
    year = {2017},
    volume = {2017},
    pages = {89--169}
  }

Rationale: These references both help place the paper methodologically and substantively in the literatures the author engages.

5. WRITING QUALITY (CRITICAL)

Overall writing is clear, well-structured, and the Introduction is compelling. A few writing issues to address:

a) Prose vs. bullets
- The main narrative uses paragraphs. The small list in institutional background and data is acceptable. No failure here.

b) Narrative flow
- The Introduction hooks the reader with the puzzle and outlines contributions clearly. The transition from micro literatures to macro implications is convincing.

c) Sentence quality
- Prose is generally crisp. Avoid overstating certainty where results are suggestive (e.g., establishment size result with p=0.108 is appropriately reported as suggestive in the text; preserve that restraint).

d) Accessibility
- Good use of intuition for econometric choices (why Callaway-Sant'Anna and Sun-Abraham). Consider adding a short boxed intuition about how TWFE contamination can flip the sign in staggered settings (a brief example or citation to Goodman-Bacon is enough).

e) Tables and notes
- Ensure tables are self-contained: define all variables in table notes, specify estimation method, clustering, bootstrapping, sample period, and what control groups are.

6. CONSTRUCTIVE SUGGESTIONS (to strengthen the paper)

The paper is promising. The following analyses/extensions would substantially improve credibility and impact:

High priority (address before next submission):
1) Incorporation-weighted exposure and firm-level analysis (see Section 3a). This is the single most important extension. Use Compustat or state incorporation records to construct treatment intensity and re-estimate at the state or firm level. Estimate treatment-on-treated and test whether results strengthen when exposure is measured correctly.

2) Provide complete inference reporting: show coefficients with cluster-robust SEs (and wild cluster bootstrap p-values), 95% CIs, N (obs), number of clusters. Report bootstrap/randomization inference procedure details.

3) Show cohort-specific ATTs or at least cohort-grouped effects in appendix. Demonstrate that results are not driven by a single cohort.

4) Formal pre-trend tests (joint F-tests) and sensitivity of pre-trend fit to inclusion/exclusion of early cohorts. If pre-trends remain a concern for net entry, explore alternative specifications or matching.

Medium priority:
5) Mechanism tests:
   - Provide evidence on M&A activity by state-year (if feasible).
   - Industry-level heterogeneity: decomposing effects into concentrated vs competitive industries or manufacturing vs services. Use HHI by industry-state if available.
   - Firm-level outcomes: investment, patenting, exit, wages (Compustat/USPTO) to link micro mechanisms.

6) Spatial/spillover tests: include neighboring states' adoption indicators and/or control for state-specific trends.

7) Robustness to alternative control groups: propensity-score matched never-treated states, or synthetic controls for selected treated states.

Lower priority / presentation:
8) Provide a figure/table listing which cohorts (states and adoption years) are used in identification, and which were dropped due to already-treated status by 1988.

9) Clarify bootstrap draw counts and number of permutations in randomization inference; increase permutation draws beyond 500 for smoother p-values (1,000 or 5,000 recommended).

7. OVERALL ASSESSMENT

Key strengths:
- Important and timely research question linking corporate governance to macro-level dynamism.
- Use of modern staggered DiD estimators, and clear discussion of TWFE contamination and heterogeneity-robust methods.
- Good presentation and clear narrative connecting micro "quiet life" literature to aggregate outcomes.

Critical weaknesses:
- Incorporation vs. location is a major identification threat; the current state-level CBP analysis may understate or mis-measure who is affected. The binary treatment indicator tied to adoption year is an imperfect measure of exposure.
- Some inference details are missing or insufficiently described: need to show SEs/CIs/number of clusters and describe bootstrap/randomization procedures in tables and notes.
- Early adopters lacking pre-period data mean identification relies on later cohorts—need more transparency about which cohorts drive results and cohort-specific ATTs.
- Mechanisms remain suggestive; stronger micro evidence (M&A, industry heterogeneity, firm-level outcomes) would greatly strengthen the causal chain.

Specific suggestions for improvement:
- Construct incorporation-weighted exposure measures (Compustat). If unavailable, document empirically whether local large employers are incorporated in the adopting states (sample of top N firms by employment per state).
- Add firm-level regressions using firm incorporation-state as treatment (Compustat panel).
- Provide cohort-specific ATTs and table with number of contributing cohorts in each event-time bin.
- Use wild cluster bootstrap and/or more extensive permutation inference, and report both asymptotic and bootstrap p-values.
- Add mechanism tests on M&A and industry heterogeneity.
- Expand literature citations to include Goodman-Bacon (2021), Sun & Abraham (2021), Cameron & Miller (2015), Bebchuk et al. (2009), and Gutiérrez & Philippon (2017).

8. DECISION (REQUIRED)

Given the promise of the paper but the need to address a major identification concern (incorporation vs. location) and to add several robustness and mechanism checks, I recommend a major revision. The required incorporation-weighted/firm-level exposure analysis is potentially demanding but is central to the paper's causal claim. If the authors can show that state-level CBP outcomes meaningfully capture legal exposure (or preferably implement incorporation-weighted/firm-level analyses showing consistent results), the paper would be a strong candidate for top general-interest journals.

DECISION: MAJOR REVISION

Appendix — Recommended BibTeX entries to add to your references

@article{goodmanbacon2021difference,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-differences with variation in treatment timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {254--277}
}

@article{sun2021estimating,
  author = {Sun, Liyang and Abraham, Sarah},
  title = {Estimating dynamic treatment effects in event studies with heterogeneous treatment effects},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {175--199}
}

@article{cameron2008bootstrap,
  author = {Cameron, A. Colin and Gelbach, Jonah B. and Miller, Douglas L.},
  title = {Bootstrap-based improvements for inference with clustered errors},
  journal = {The Review of Economics and Statistics},
  year = {2008},
  volume = {90},
  pages = {414--427}
}

@article{cameron2015practical,
  author = {Cameron, A. Colin and Miller, Douglas L.},
  title = {A practitioner's guide to cluster-robust inference},
  journal = {Journal of Human Resources},
  year = {2015},
  volume = {50},
  pages = {317--372}
}

@article{bebchuk2009what,
  author = {Bebchuk, Lucian A. and Cohen, Alma and Ferrell, Allen},
  title = {What matters in corporate governance?},
  journal = {The Review of Financial Studies},
  year = {2009},
  volume = {22},
  pages = {783--827}
}

@article{gutierrez2017investment,
  author = {Gutiérrez, Germán and Philippon, Thomas},
  title = {Investment-less growth: An empirical investigation},
  journal = {Brookings Papers on Economic Activity},
  year = {2017},
  volume = {2017},
  pages = {89--169}
}

Final encouragement: the paper tackles an important question with the right modern econometric tools and a compelling narrative. Address the incorporation exposure and inference/reporting gaps, add mechanism and heterogeneity evidence, and the paper will make a significant contribution to debates about corporate governance and macro-level dynamism.